The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis
ABSTRACTAcute disseminated encephalomyelitis (ADEM) has been identified as an Adverse Event of Special Interest in the COVID-19 vaccine programme due to its long-standing temporal association with a wide range of other vaccines. Case reports of ADEM shortly following COVID−19 vaccination have now be...
Saved in:
Main Authors: | Julia Stowe (Author), Jamie Lopez-Bernal (Author), Nick Andrews (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute disseminated encephalomyelitis (ADEM) and systemic lupus erythematosus (SLE) in children: What relationship?
by: S. Safadi, et al.
Published: (2024) -
Acute disseminated encephalomyelitis and routine childhood vaccinations - a self-controlled case series
by: T. J. Martin, et al.
Published: (2021) -
Acute Disseminated Encephalomyelitis
by: Roberto Lotti Mesa
Published: (2017) -
Acute Disseminated Encephalomyelitis
by: J Gordon Millichap
Published: (2005) -
Acute Disseminated Encephalomyelitis
by: J Gordon Millichap
Published: (2001)